Biogen (BIIB) Work In Process (2010 - 2018)

Biogen has reported Work In Process for 9 years, with the latest figure at $606.7 million in Q4 2018.

• On a quarterly basis, Work In Process changed 0.17% year-over-year to $606.7 million in Q4 2018; TTM through Dec 2018 was $606.7 million, a 0.17% change from a year earlier, with the FY2018 full-year figure at $606.7 million, changed 0.17% from the prior year.
• Work In Process was $606.7 million for Q4 2018 at Biogen, roughly flat from $605.7 million in the prior quarter.
• The five-year high for Work In Process was $698.7 million in Q4 2016, with the low at $511.5 million in Q4 2014.
• Average Work In Process over 5 years is $600.0 million, with a median of $605.7 million recorded in 2017.
• The sharpest annual moves came in 2016 and 2017: Work In Process advanced 20.97% in 2016, then fell 13.31% in 2017.
• Over 5 years, Work In Process stood at $511.5 million in 2014, then rose by 12.92% to $577.6 million in 2015, then rose by 20.97% to $698.7 million in 2016, then dropped by 13.31% to $605.7 million in 2017, then increased by 0.17% to $606.7 million in 2018.
• The last three Work In Process figures came in at $606.7 million (Q4 2018), $605.7 million (Q4 2017), and $698.7 million (Q4 2016), per Business Quant data.